NSIS-B:CPH
Novozymes A/S
DKKÂ 426.80
arrow_downward
-1.20%(-5.20) 1D
Sep 17, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKKÂ 430.70
High
DKKÂ 431.90
Low
DKKÂ 425.70
Mkt. cap
179.09B
Avg. vol.
567.61K
Volume
492.43K
52-wk high
DKKÂ 465.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKKÂ 430.70
High
DKKÂ 431.90
Low
DKKÂ 425.70
Mkt. cap
179.09B
Avg. vol.
567.61K
Volume
492.43K
52-wk high
DKKÂ 465.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 day ago
Novonesis stock starts EUR 1 billion buyback program and trades steady
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S